Jim Cramer: Danaher Stock Overvalued at 21 Times Earnings

Financial commentator Jim Cramer said Danaher Corporation (NYSE: DHR) is trading at overvalued levels. He made the comment while discussing the recent rally in AI-related stocks.

Recommendation Change

Cramer did not issue a buy or sell recommendation, but noted that the stock at 21x earnings appears overvalued relative to its organic growth rate.

Analyst's Rationale

Cramer believes Danaher, once among the most revered companies in the market, no longer justifies its high valuation multiple given its slowing organic growth. He suggested investors may find better opportunities elsewhere.

Context

Cramer's remarks come as tech and AI stocks surge, potentially prompting investors to reassess healthcare stocks like Danaher. The stock has declined 5% over the past month.

What to Make of It

Cramer's comment is not a direct recommendation but highlights the importance of comparing valuation to growth. Investors should conduct their own analysis before making decisions.